Found 1135 matching trials
biomArkers to differeNtiate bacTerial From vIral iNfEctions NA ANTOINE is a prospective trial which aims to assess diagnostic performance ...
Show More Location
Hospices Civils de Lyon
Learn More & Join Trial
Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma NA The study aims at:
1. Perform a multilayer analysis relying on tight integ...
Show More Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Learn More & Join Trial
Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer PHASE2 This is a phase II Randomized comparison clinical trial of activated CIK ar...
Show More Location
Institutional Review Board of Guangzhou Fuda Cancer Hospital
Learn More & Join Trial
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer PHASE3 This phase III trial compares the effect of sentinel lymph node mapping to ...
Show More Location
George Washington University Medical Center
Learn More & Join Trial
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA PHASE2 This phase II trial examines the use of blood-based biomarkers is to help i...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial
Diagnostic Research in Patients With Rare Diseases -Solving the Unsolved Rare Diseases N/A Most diagnostically unsolved rare disease have a genetic cause. These cause...
Show More Learn More & Join Trial
Convalescent Plasma for Treatment of COVID-19 PHASE2 Convalescent plasma has been shown to be safe and effective for treatment o...
Show More Location
Department of Infectious Disease, Falu Hospital
Learn More & Join Trial
Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation PHASE1 RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Show More Location
Mayo Clinic Scottsdale
Learn More & Join Trial
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study PHASE3 This phase III trial compares the effect of adding cabozantinib to avelumab...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Learn More & Join Trial
Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working PHASE2 This phase II/III trial compares the effect of the combination treatment wi...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial